Oct 24, 2023 / 11:00AM GMT
Presentation
Oct 24, 2023 / 11:00AM GMT
=====================
Corporate Participants
=====================
* Jeff Legos
Novartis AG - Senior VP & Global Program Head of Oncology
* Samir Shah
Novartis AG - Global Head of IR
* Shreeram Aradhye
Novartis AG - President of Global Drug Development & Chief Medical Officer
=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Gary Steventon
BNP Paribas Exane, Research Division - Research Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* Mark Douglas Purcell
Morgan Stanley, Research Division - Equity Analyst
* Michael Thomas Nedelcovych
TD Cowen, Research Division - Research Associate
* Peter James Welford
Jefferies LLC, Research Division - Senior Equity Analyst & European Pharmaceuticals Analyst
*
Novartis AG
(XSWX:NOVN)
CHF
93.09
0.23 (0.25%)
Market Cap: 186.11 Bil
Enterprise Value: 202.00 Bil
PE Ratio: 12.54
PB Ratio: 5.07
GF Score: 81/100 Novartis AG PSMAfore Data at ESMO Presentation Transcript
Oct 24, 2023 / 11:00AM GMT
Release Date Price:
CHF85.11
(+0.72%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot